Virtual Events North America
We at NanoString want to support you in advancing your scientific endeavors, providing technical talks covering a variety of topics. Register to attend our webinar events live, or browse our bank of on-demand recordings!

Offerings include technical application overviews, special guest speakers, publication reviews, data analysis support, grant and publication writing tips and tricks, and much more!

Have an idea or request for a webinar topic? Contact us at rmamericas@nanostring.com!

Upcoming Virtual Events

Advancing Science: Virtual Immunology Conference


Speakers: Drs. James Heath, Chris Mason, Peter Mombaerts, Richard Danger, Fadi Issa, Michael Mengel

The immune system plays a major role in the onset and progression of different disorders such as autoimmunity, infectious disease, and organ rejection.  Insights into the dynamics of the immune response, inflammation, and tissue damage can help researchers better understand how to treat the immune system as well as disease symptoms to avoid systemic hyperinflammation and organ damage. Join us for this virtual conference that brings together researchers, scientists, and clinicians from around the world to learn and discuss recent advances in immunology research with a focus on the latest topics and trends in infectious disease and organ transplantation.  We will discuss the impact of the COVID-19 pandemic on these research areas as well as the role that gene expression profiling, both bulk and spatial, has in future discoveries.

A ROSALIND® Case Study: The role of Glial Cells in CNS inflammation


Join us for an overview of the ROSALIND® cloud platform for nCounter® data analysis as well as a showcase of a study by Philip Hasel et al. from NYU Langone Health about the role of glial cells, specifically astrocytes, in CNS inflammation.  Astrocytes are the most abundant cell type in the brain and play pivotal roles in brain homeostasis. In both acute and chronic disease, however, they can undergo a transition into one of several ‘reactive’ states. In this study, the researchers profiled the temporal transcriptomic response in mouse brain tissue exposed to the endotoxin lipopolysaccharide (LPS) to uncover drastic temporal changes in gene expression during neuroinflammation..

NanoString nCounter Community Meeting -

North America


Bringing together the great minds of NanoString's Expression Profiling Technology!
Join us for a half-day event featuring discussion sessions led by nCounter power users across North America, NanoString technical scientists, and service lab and research and development teams.
Featuring special guest moderators and speakers from across North America! Register to receive the full agenda.

New Product Announcement!

“Linking” it All Together: Enhancing ADC Development with the NEW nCounter® ADC Development Panel


Antibody-drug conjugates (ADCs) represent a targeted form of drug delivery that has been gaining increased interest and advancement in the oncology space. Traditional chemotherapy can expose healthy, non-cancerous cells to cytotoxic effects, resulting in numerous adverse events. ADCs, to the contrary, link cytotoxic agents to an antibody that targets a specific antigen on a cancer cell. This results in precise delivery of the toxic agent to the targeted cancer cell of interest. The development of ADCs, however, requires multiple steps in a complex process that combines chemistry and biology for delivery and release of the drug.
The novel nCounter® ADC Development Panel was created to address complex questions critical for the success of Antibody Drug Conjugates throughout discovery, pre-clinical and clinical development.  Biological function can be assessed using quantitative molecular characterization spanning 6 stages in the lifecycle of the ADC, including:
  • Mechanisms of resistance
  • Immunogenic cell death
  • Aspects of the immune response
  • Traditional and emerging MOAs
  • Current and developing targets for ADCs..


Newly-released On-Demand

A ROSALIND® Case Study: Two are better than one, looking for suitable biomarkers


Learn how the nCounter® PanCancer IO 360™ Panel aids your research by providing insights on your “hot” and “cold” tumors. In this study a cohort of 23 colorectal cancer (CRC) samples with known genomic stability status and Tumor Inflammation Score were analyzed using ROSALIND software. As MSS tumors have been referred to as “cold” and MSI tumors as “hot”, the nCounter® PanCancer IO 360™ Panel was used to investigate the transcription changes associated with both TIS and genomic stability status and to identify other putative regulators of the transcriptional changes.

NanoString Basics: A Journey from nCounter Expression Profiling through GeoMx Digital Spatial Technology

Transforming Human Health: New Developments in Cell and Gene Therapy Research

Dog Days of Summer- A Panel Discussion on Comparative Canine Oncology

In this panel discussion we will meet with world leading veterinary oncologists alongside human oncologists and members of the NCI’s Cancer Moonshot program to discuss how Comparative Canine Oncology is being used to save canine lives and improve treatments and clinical trials for human studies.
Learn more about:
• Top cancer challenges that canines and man are tackling together
• Key research within the field of comparative oncology
• How lessons are being translated to benefit human and canines
• The creation of the NanoString Canine IO Panel

Moderator:

Peter C. Adamson, MD
Global Head, Oncology Drug Development
& Lead Pediatric Innovations Group, Sanofi, Inc.

Speakers:

Nicola Mason, BVetMed, PhD
Professor of Medicine & Pathobiology
University of Pennsylvania School of Veterinary Medicine
Steven Dow, DVM, PhD
Professor of Immunology, Director of the Center for Immune and Regenerative Medicine
Colorado State University
Melissa Chambers, DVM, MD
Professor of Neuroscience, Diplomate of the American Board of Neurological Surgeons
University of Alabama
Troy McEachron, PhD
Investigator, Pediatric Oncology Branch
NCI/NIH
Amy LeBlanc, DVM DACVIM
Director of the Comparative Oncology Program
NCI/NIH

COVID-19 One Year Later: A Host Response Symposium

Join us for a short symposium featuring scientific talks and a panel discussion around COVID-19 research and how it has impacted the future of infectious disease studies as we celebrate the one year anniversary of the launch of the nCounter® Host Response Panel, a 785-plex, pathogen-agnostic panel for studying the innate and adaptive host immune response to invading pathogens.

  • The nCounter Host Response Panel as Part of the Infectious Disease Toolbox - Presented by Elizabeth Schneider, PhD, Senior Global Marketing Manager, NanoString Technologies, Inc.

  • An investigation of Type I IFN driven immunity against SARS-CoV-2 - Presented by Jonathan Lopez, PhD, PharmD, Medical Biologist, LBMMS of the CHU de Lyon, Department of Biochemistry and Molecular Biology, Lyon East Faculty of Medicine, & Lyon Cancer Research Center

  • SARS-CoV-2 infection induces strong type I Interferon (IFN) immunity in both blood and nasopharyngeal mucosa of mildly symptomatic COVID-19 patients, but this response is compromised in critically ill patients with autoantibodies against type I IFNs.  

  • Determining a role for SARS-CoV-2 membrane protein in COVID-19 pathogenesis - Presented by Yusuf Omosun, PhD, Assistant Professor Microbiology, Biochemistry & Immunology, Morehouse School of Medicine

  • A self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice - Presented by Esther Shuyi Gan, PhD, Research Fellow, Duke-NUS Medical School

  • How has the advent of the COVID-19 pandemic changed the face of infectious disease research?  A Panel Discussion with Drs. Lopez, Omosun, and Gan

Data Analysis Training
nSolver Basic Analysis & Advanced Analysis Trainings are available On-Demand!


Newly Released On-Demand
Missed one of our events? Don't worry, all of our events can be viewed on-demand at your leisure. VIEW ON-DEMAND
AACR Spotlight Theater Presentations

True Spatial Genomics: Measuring the Transcriptome in Regions, Cell and Sub-Cellular Compartments
Joseph Beechem, PhD, Chief Scientific Officer & Senior VP of R&D, NanoString Technologies
New Approaches for CAR-T Cell Therapies: Technology Symposium featuring GeoMx Spatial Profiling and nCounter CAR-T Characterization
Ryan J. Golden, M.D., PhD, Marco Ruella, M.D., & Ghamdan Al-Eryani

Spatial Genomics in Cancer Research is

NOW AVAILABLE TO VIEW ON-DEMAND


Sequencing-based spatial analyses allow researchers to study the tumor microenvironment in situ and understand the dynamic relationship between the tumor and its microenvironment. Spatial genomics offers an unbiased view of cancer biology and true discovery power for drug targets and biomarkers.



Questions or comments regarding a presentation?
Please reach out to: NanoString Regional Marketing | rmamericas@nanostring.com